Related Experiment Video
Updated: Jul 14, 2026
06:49
A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS
Published on: October 6, 2015
Using disease progression models as a tool to detect drug effect
D R Mould1, N G Denman, S Duffull
1Projections Research Inc., Phoenixville, Pennsylvania, USA. drmould@attglobal.net
Clinical Pharmacology and Therapeutics
|May 18, 2007
Summary
Confirmatory clinical trials provide dichotomous drug approval data, but prescribers need nuanced information for real-world patient care decisions. More clinically relevant trial designs are essential for effective drug use.
Area of Science:
- Clinical trial design
- Pharmacovigilance
- Evidence-based medicine
Background:
- Drug approval relies on binary efficacy and safety data from confirmatory trials.
- Current trial designs primarily test null hypotheses for regulatory approval.
Purpose of the Study:
- To highlight the discrepancy between regulatory approval data and clinical decision-making needs.
- To advocate for clinical trial designs that better inform prescriber choices.
Main Methods:
- Analysis of the limitations of traditional hypothesis testing in clinical trials.
- Discussion of the information gap between trial results and clinical practice.
Main Results:
- Confirmatory trials offer limited utility for individual patient treatment decisions.
- Prescribers face challenges in dose adjustment and drug selection due to trial data.
Conclusions:
- Existing clinical trial frameworks inadequately support clinical practice.
- There is a critical need for trial methodologies that address real-world patient complexities and risk-benefit assessments.
Related Concept Videos
01:09Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
01:29Pharmacodynamic Models: Direct Effect Model and Indirect Response Model
Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...
01:18Pharmacodynamic Models: Emax Drug–Concentration Effect Model
The Emax drug-concentration effect model is central to pharmacodynamics in drug discovery and development. This model is predicated on the receptor occupancy theory, which posits that the effect of a drug is directly related to the number of receptors occupied by the drug and the resultant complex formation.The model describes the reversible interaction between a drug (C) and a receptor (R) to form a drug-receptor complex (RC). The kinetics of this interaction are quantified by an equation that...
01:27Pharmacodynamic Models: Overview
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:14Time Course of Drug Effect
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50 percent of...